Zoetis (ZTS) Asset Utilization Ratio (2013 - 2026)
Zoetis' (ZTS) quarterly Asset Utilization Ratio came in at 0.62 in Q1 2026, down 5.21% year-on-year from 0.65 in Q1 2025, and up 0.69% on a QoQ basis from 0.62 in Q4 2025.
Zoetis (ZTS) Asset Utilization Ratio (2013 - 2026) Analysis & Trends
Zoetis (ZTS) has 14 years of Asset Utilization Ratio data on file, last reported at 0.62 in Q1 2026.
- On a quarterly basis, Asset Utilization Ratio fell 5.21% year-over-year to 0.62 in Q1 2026; TTM through Mar 2026 was 0.62, a 5.21% decrease from a year earlier, with the FY2025 full-year figure at 0.64, down 1.87% from the prior year.
- Asset Utilization Ratio for Q1 2026 stood at 0.62, up from 0.62 in the prior quarter.
- Over the last five years, Asset Utilization Ratio for ZTS reached as high as 0.66 in Q2 2025 and fell as low as 0.56 in Q1 2023.
- Historically, Asset Utilization Ratio has averaged 0.61 across 5 years, with a median of 0.61 in 2024.
- Across the five-year window, Asset Utilization Ratio grew 11.1% in 2022 and retreated 5.21% in 2026, its largest moves.
- Year by year, Asset Utilization Ratio stood at 0.57 in 2022, then advanced by 6.51% to 0.6 in 2023, then gained by 7.71% to 0.65 in 2024, then decreased by 4.92% to 0.62 in 2025, then gained by 0.69% to 0.62 in 2026.
- Per Business Quant data, the three most recent Asset Utilization Ratio figures were 0.62 in Q1 2026, 0.62 in Q4 2025, and 0.63 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 0.43 |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 0.62 |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 0.46 |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 0.43 |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 0.39 |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 0.65 |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 0.37 |
| 10 | Vireo Growth | 10.53 Bn | 10.38 Bn | 59.30 Mn | 0.40 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.62 |
| Dec 31, 2025 | 0.62 |
| Sep 30, 2025 | 0.63 |
| Jun 30, 2025 | 0.66 |
| Mar 31, 2025 | 0.65 |
| Dec 31, 2024 | 0.65 |
| Sep 30, 2024 | 0.64 |
| Jun 30, 2024 | 0.63 |
| Mar 31, 2024 | 0.61 |
| Dec 31, 2023 | 0.60 |
| Sep 30, 2023 | 0.60 |
| Jun 30, 2023 | 0.60 |
| Mar 31, 2023 | 0.56 |
| Dec 31, 2022 | 0.57 |
| Sep 30, 2022 | 0.58 |
| Jun 30, 2022 | 0.58 |
| Mar 31, 2022 | 0.57 |
| Dec 31, 2021 | 0.56 |
| Sep 30, 2021 | 0.55 |
| Jun 30, 2021 | 0.53 |